Therapeutic Asset Ratings

6,538 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Gemtuzumab Acute Myeloblastic Leukemia	M.D. Anderson Cancer Center	P4	A (81)
Benmelstobart Limited Stage Small Cell Lung Cancer	Yayi He	P4	A (80)
Lanadelumab Hereditary Angioedema (HAE)	Takeda	P3	A (80)
Denosumab Bone Metastases	Kelly Fitzgerald, MD	P4	BBB (79)
Eptinezumab Migraine	Stanford University	P4	BBB (79)
Eptinezumab Medication Overuse Headache	Beijing Tiantan Hospital	P4	BBB (78)
Galcanezumab Migraine	Stanford University	P4	BBB (78)
Garadacimab Hereditary Angioedema	CSL Behring	P4	BBB (78)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Recurrent Adult Burkitt Lymphoma	AIDS Malignancy Consortium	P4	BBB (78)
Immunoglobulin G4 [230-proline,de-449-lysine], anti-(human blood-coagulation factor IX)(human clone 0365-0001-9985 ?4-chain), disulfide with human clone 0365-0001-9985 ?-chain, (228?226?),(231?229?)-bis(disulfide) with anti-(human blood-coagulation factor X) immunoglobulin G4 [228-proline,405-leucine,409-lysine,de-447-lysine] (human clone 0365-0001-8174 ?4-chain) disulfide with human clone 0365-0001-8174 ?-chain Haemophilia A	Novo Nordisk A/S	P3	BBB (78)
Emicizumab Hemophilia A	Emory University	P4	BBB (77)
IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER Pancreatic Cancer, Adult	Chinese PLA General Hospital	P4	BBB (76)
Omalizumab Allergic Asthma	Qianfoshan Hospital	P4	BBB (76)
TRASTUZUMAB Stage IV Breast Cancer	SWOG Cancer Research Network	P4	BBB (76)
Necitumumab Metastatic Lung Non-Small Cell Carcinoma	Jonsson Comprehensive Cancer Center	P3	BBB (76)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Recurrent Adult Lymphoblastic Lymphoma	University of Washington	P4	BBB (75)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER Breast Cancer Female NOS	SWOG Cancer Research Network	P3	BBB (75)
Fremanezumab Migraine	University of Aarhus	P4	BBB (74)
Humax-Cd20 Relapsing Multiple Sclerosis	University Hospital, Montpellier	P4	BBB (74)
IMMUNOGLOBULIN G, ANTI-(HUMAN CALCITONIN GENE-RELATED PEPTIDE RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER Migraine	Stanford University	P4	BBB (74)
TRASTUZUMAB HER2/Neu Positive	Northwestern University	P3	BBB (74)
TRASTUZUMAB Inflammatory Breast Cancer	Hoffmann-La Roche	P3	BBB (74)
Nivolumab Recurrent Non-Hodgkin Lymphoma	University of Pittsburgh	P2/3	BBB (74)
Emicizumab Severe Hemophilia A	Chulalongkorn University	P4	BBB (73)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER B-cell Chronic Lymphocytic Leukemia	Zulfa Omer	P4	BBB (73)

Showing 1 to 25 of 6,538 assets

PreviousPage 1 of 262Next